This story has rotated off the live feed but the permalink stays available for sharing and search.

news Scmp World 2026-06-01

Akeso's Lung Cancer Drug Shows Promise in Clinical Trials

Akeso's drug ivonescimab has demonstrated strong clinical results for a type of lung cancer, potentially capturing a significant share of the US$20 billion market and leading to upward revisions in target prices.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10